The U.S. Department of Transportation published a final rule April 23 that makes technical corrections to regulations governing drug testing for safety-sensitive employees to ensure consistency with recent amendments made to DOT’s “Procedures for Transportation Workplace Drug and Alcohol Testing Programs,” which recently added requirements for testing for oxycodone, oxymorphone, hydrocodone and hydromorphone.
According to the release from DOT, the new changes to the department’s regulations make it necessary to refer to these substances, as well as morphine, 6-acetylmorphine and codeine by the term “opioids” rather than “opiates.”
This final rule amends the term in the FAA, FTA and PHMSA regulations to ensure that all DOT drug testing rules are consistent with one another and the mandatory guidelines for the testing program.
Click here to read more about this final rule.
Related News
- Local #823 member killed in on-duty collision
- The Safety Of Our BNSF Brothers And Sisters Is Not For Sale!
- Tragic Collision in Pecos, Texas Claims Two Lives
- SMART-TD union announces the passage of the Railroad Employee Equity and Fairness Act (REEF)
- SMART-TD member elected to lead Kansas worker group
- SMART-TD condemns Union Pacific’s lease to Central Oregon Pacific Railroad
- Sharp-eyed conductor saves two lives in winter crossing accident
- Union Takes Bold Step To Force Congress To Act On Rail Safety
- Fundraiser established for fallen brother, Local Chairperson of 1518, Steve Bryant
- Railroad and Transit Union officers continue streak as top grassroots lobbyists